DSM and Firmenich confirm leadership team for proposed combined company DSM-Firmenich - Seite 2

technology with deep expertise across a global network of 15 R&D facilities,
which will be led by Dr. Sarah Reisinger . Sarah, a US national, holds a Ph.D.
in Microbiology from the University of California, Berkeley and has extensive
experience in biology and related fields, previously serving in leadership roles
at Ginkgo Bioworks and Amyris. She joined Firmenich in 2018 to lead the
company's biotechnology and process engineering teams before taking on her
current position of Chief Research Officer in 2021.

DSM-Firmenich will have four high-performing and complementary businesses, all
with pioneering, leadership positions and each led by a member of the future
Executive Committee.

Perfumery & Beauty, incorporating Firmenich's Fragrance and Ingredients
divisions and DSM's Personal Care & Aroma business, will be led by Ilaria Resta
, who is currently Firmenich's President of Perfumery. Ilaria, an Italian-Swiss
national, is an internationally awarded industry leader who joined Firmenich in
2020 after two decades with Procter & Gamble during which she was responsible
for building some of the world's leading home and personal care brands.

Patrick Niels , DSM's Executive Vice President Food & Beverage, will lead the
combined Food & Beverage/Taste & Beyond business in establishing a global-scale
partner for the industry with extensive capabilities in taste, nutrition and
functionality. Patrick, a Dutch-US national, began his career at Gist-Brocades
in 1991, which was acquired by DSM in 1998. He has since held various leadership
roles across the company in different businesses and in various regions
including almost nine years in the US where, amongst others, he was responsible
for both North and South America.

DSM's Executive Vice President Health, Nutrition & Care, Philip Eykerman , will
continue to lead this business' development of customized quality end-to-end
solutions that support the health of people at every life stage. Philip, a
Belgian national, left McKinsey & Company in 2011 to oversee DSM's corporate
strategy and M&A as Executive Vice President Corporate Strategy & Acquisitions.
Since 2020, he has been responsible for all of DSM's activities in human
nutrition and health, as well as M&A across the company.

Ivo Lansbergen , who was appointed DSM's Executive Vice President for Animal
Health & Nutrition in 2019, will continue to lead this business in developing
solutions to alleviate pressure on the planet's finite natural resources while
satisfying the increasing demand for protein. Ivo, a Dutch national, has been
with DSM since 1997 during which time he has held various senior positions in